Analyst Michael Wiederhorn works at OPPENHEIMER and is focused on the Healthcare sector with 487 price targets and ratings documented since 2008 spanning on 13 stocks. Analyst's average stock valuation to be materialised ratio is 81.22% with an average time for price targets to be met of 265.38 days.
Most recent stock forecast was given on AMED, Amedisys, Inc at 28-Oct-2022.
Michael Wiederhorn best performing recommendations are on CYH (COMMUNITY HEALTH SYSTEMS, INC).
The best stock recommendation documented was for CHE (CHEMED CORPORATION) at 10/26/2015. The price target of $152 was fulfilled within 2 days with a profit of $6.57 (4.52%) receiving and performance score of 22.59.
Average potential price target upside